HIV1/tuberculosis coinfection

From Aaushi
Jump to navigation Jump to search

Introduction

also see HIV1, AIDS, & tuberculosis

Complications

Management

More general terms

Additional terms

References

  1. 1.0 1.1 Journal Watch, Massachusetts Medical Society October 20, 2011
    Abdool Karim SS et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med 2011 Oct 20; 365:1492. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22010915
    Havlir DV et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med 2011 Oct 20; 365:1482. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22010914
    Blanc FX et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med 2011 Oct 20; 365:1471. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22010913
    Torok ME and Farrar JJ. When to start antiretroviral therapy in HIV-associated tuberculosis. N Engl J Med 2011 Oct 20; 365:1538. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22010921
  2. 2.0 2.1 2.2 Centers for Disease Control and Prevention (CDC) Announcement: Updated guidelines on managing drug interactions in the treatment of HIV-related tuberculosis. Morb Mortal Wkly Rep MMWR 2014 Mar 28; 63:272. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6312a5.htm
    Centers for Disease Control and Prevention (CDC). Managing drug interactions in the treatment of HIV-related tuberculosis. June 2013. http://www.cdc.gov/tb/publications/guidelines/TB_HIV_Drugs/pdf/tbhiv.pdf
  3. 3.0 3.1 3.2 Medical Knowledge Self Assessment Program (MKSAP) 17, 18, 19. American College of Physicians, Philadelphia 2015, 2018, 2021.
  4. 4.0 4.1 Meintjes G, Stek C, Blumenthal L et al. Prednisone for the prevention of paradoxical tuberculosis- associated IRIS. N Engl J Med 2018 Nov 15; 379:1915. PMID: https://www.ncbi.nlm.nih.gov/pubmed/30428290 https://www.nejm.org/doi/10.1056/NEJMoa1800762